[논문]Cerebrospinal Fluid Profiles and Their Changes after Intraventricular Chemotherapy as Prognostic or Predictive Markers for Patients with Leptomeningeal Carcinomatosis

Kwon, Ji-Woong; Shim, Youngbo; Gwak, Ho-Shin; Park, Eun Young; Joo, Jungnam; Yoo, Heon; Shin, Sang-Hoon

doi:10.3340/jkns.2020.0300

Cerebrospinal Fluid Profiles and Their Changes after Intraventricular Chemotherapy as Prognostic or Predictive Markers for Patients with Leptomeningeal Carcinomatosis 원문보기

Journal of Korean Neurosurgical Society = 대한신경외과학회지, v.64 no.4, 2021년, pp.631 - 643

Kwon, Ji-Woong (Neuro-oncology Clinic, National Cancer Center) , Shim, Youngbo (Department of Neurosurgery, Seoul National University College of Medicine) , Gwak, Ho-Shin (Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy) , Park, Eun Young (Biostatistics Collaboration Team, National Cancer Center) , Joo, Jungnam (Biostatistics Collaboration Team, National Cancer Center) , Yoo, Heon (Neuro-oncology Clinic, National Cancer Center) , Shin, Sang-Hoon (Neuro-oncology Clinic, National Cancer Center)

Abstract ▼ AI-Helper

Objective : Here, we evaluated whether cerebrospinal fluid (CSF) profiles and their changes after intraventricular chemotherapy for leptomeningeal carcinomatosis (LMC) could predict the treatment response or be prognostic for patient overall survival (OS) along with clinical factors. Methods : Paired 1) pretreatment lumbar, 2) pretreatment ventricular, and 3) posttreatment ventricular samples and their CSF profiles were collected retrospectively from 148 LMC patients who received Ommaya reservoir installation and intraventricular chemotherapy. CSF profile changes were assessed by calculating the differences between posttreatment and pretreatment samples from the same ventricular compartment. CSF cell counts were further differentiated into total and other based on clinical laboratory reports. Results : For the treatment response, a decreased CSF 'total' cell count tended to be associated with a 'controlled' increase in intracranial pressure (ICP) (p=0.059), but other profile changes were not associated with either the control of increased ICP or the cytology response. Among the pretreatment CSF profiles, lumbar protein level and ventricular cell count were significantly correlated with OS in univariable analysis, but they were not significant in multi-variable analysis. Among CSF profile changes, a decrease in 'other' cell count showed worse OS than 'no change' or increased groups (p=0.001). The cytological response was significant for OS, but the hazard ratio of partial remission was paradoxically higher than that of 'no response'. Conclusion : A decrease in other cell count of CSF after intraventricular chemotherapy was associated with poor OS in LMC patients. We suggest that more specific CSF biomarkers of cancer cell origin are needed.

주제어

표/그림 (8)

그림 Fig. 1. Flow diagram of patient selection. LMC : leptomeningeal carcinomatosis, CSF : cerebrospinal fluid.
표 Table 1. Pretreatment clinical characteristics of the patients with leptomeningeal carcinomatosis (n=148)
그림 Fig. 2. Interaction plot depicting changes in the (A) total cell count, (B) other cell count, and (C) protein level between pretreatment and posttreatment ventricular CSF samples. After the intraventricular chemotherapy, total cell count and 'other cell count' were decreased significantly (to mean 7.8 and 2.6 cells/mm³, respectively). In contrast to the CSF cell count, the CSF protein level was significantly increased after the treatment (to 48.2 mg/dL, p=0.014). See details in the Results section. CSF : cerebrospinal fluid.
표 Table 2. The profiles of pretreatment ventricular and lumbar CSF and the change of those profiles after the intraventricular chemotherapy
표 Table 3. Association between the changes of CSF profile changes and the treatment response
표 Table 4. Analysis of clinical variables with CSF profiles and their changes after intraventricular chemotherapy on patients' overall survival
표 Table 4. Continued
그림 Fig. 3. Kaplan-Meier plot of patient overall survival according to variables that were significant in the multivariable analysis : (A) age (<60 vs. ≥60 years), (B) rounds of intraventricular methotrexate administration (<5 vs. ≥5), (C) CSF cytology conversion, and (D) change in the CSF cell count (other). MTX : methotrexate, CSF : cerebrospinal fluid.

참고문헌 (45)

1 Ahn JH Lee SH Kim S Joo J Yoo H Lee SH Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection J Neurosurg 116 984 993 2012 22339161
2 An YJ Cho HR Kim TM Keam B Kim JW Wen H An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients Int J Cancer 136 162 171 2015 24798643

상세보기
3 Balm M Hammack J Leptomeningeal carcinomatosis. Presenting features and prognostic factors Arch Neurol 53 626 632 1996 8929170

상세보기
4 Boogerd W Hart AA van der Sande JJ Engelsman E Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment Cancer 67 1685 1695 1991 2001559
5 Boogerd W van den Bent MJ Koehler PJ Heimans JJ van der Sande JJ Aaronson NK The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study Eur J Cancer 40 2726 2733 2004 15571954

상세보기
6 Bruna J Gonzalez L Miro J Velasco R Gil M Tortosa A Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features Cancer 115 381 389 2009 19109820
7 Chamberlain MC Radioisotope CSF flow studies in leptomeningeal metastases J Neurooncol 38 135 140 1998 9696363

상세보기
8 Chamberlain MC Leptomeningeal metastasis Curr Opin Oncol 22 627 635 2010 20689429

상세보기
9 Chamberlain MC Glantz M Groves MD Wilson WH Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment Semin Oncol 36 4 Suppl 2 S35 S45 2009 19660682
10 Chamberlain MC Kormanik P Carcinoma meningitis secondary to nonsmall cell lung cancer: combined modality therapy Arch Neurol 55 506 512 1998 9561978

상세보기
11 Chamberlain MC Kormanik PA Glantz MJ A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases Neuro Oncol 3 42 45 2001 11305416
12 Clamon G Doebbeling B Meningeal carcinomatosis from breast cancer: spinal cord vs. brain involvement Breast Cancer Res Treat 9 213 217 1987 3663957

상세보기
13 de Azevedo CR Cruz MR Chinen LT Peres SV Peterlevitz MA de Azevedo Pereira AE Meningeal carcinomatosis in breast cancer: prognostic factors and outcome J Neurooncol 104 565 572 2011 21234642

상세보기
14 Fizazi K Asselain B Vincent-Salomon A Jouve M Dieras V Palangie T Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen Cancer 77 1315 1323 1996 8608509
15 Freilich RJ Krol G DeAngelis LM Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis Ann Neurol 38 51 57 1995 7611725

상세보기
16 Gauthier H Guilhaume MN Bidard FC Pierga JY Girre V Cottu PH Survival of breast cancer patients with meningeal carcinomatosis Ann Oncol 21 2183 2187 2010 20430906

상세보기
17 Glantz MJ Hall WA Cole BF Chozick BS Shannon CM Wahlberg L Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status Cancer 75 2919 2931 1995 7773943
18 Glass JP Melamed M Chernik NL Posner JB Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology Neurology 29 1369 1375 1979 573381

상세보기
19 Gleissner B Chamberlain MC Neoplastic meningitis Lancet Neurol 5 443 452 2006 16632315

상세보기
20 Grossman SA Krabak MJ Leptomeningeal carcinomatosis Cancer Treat Rev 25 103 119 1999 10395835

상세보기
21 Groves MD Glantz MJ Chamberlain MC Baumgartner KE Conrad CA Hsu S A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies Neuro Oncol 10 208 215 2008 18316473
22 Gwak HS Joo J Kim S Yoo H Shin SH Han JY Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer J Thorac Oncol 8 599 605 2013 23422833

상세보기
23 Gwak HS Joo J Shin SH Yoo H Han JY Kim HT Ventriculolumbar perfusion chemotherapy with methotrexate for treating leptomeningeal carcinomatosis: a phase II study Oncologist 19 1044 1045 2014 25209375

상세보기
24 Harstad L Hess KR Groves MD Prognostic factors and outcomes in patients with leptomeningeal melanomatosis Neuro Oncol 10 1010 1018 2008 18708343
25 Herrlinger U Forschler H Kuker W Meyermann R Bamberg M Dichgans J Leptomeningeal metastasis: survival and prognostic factors in 155 patients J Neurol Sci 223 167 178 2004 15337619

상세보기
26 Hitchins RN Bell DR Woods RL Levi JA A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis J Clin Oncol 5 1655 1662 1987 3309199

상세보기
27 Hyun JW Shin HS Kim SH Kong SY Yoo H Gwak HS CYFRA 21-1 levels in cerebrospinal fluid as a putative therapeutic monitoring biomarker for patients with leptomeningeal carcinomatosis: a pilot study Cancer Biomark 28 81 89 2020 32176621
28 Jayson GC Howell A Carcinomatous meningitis in solid tumours Ann Oncol 7 773 786 1996 8922190

상세보기
29 Lee JS Melisko ME Magbanua MJ Kablanian AT Scott JH Rugo HS Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer Breast Cancer Res Treat 154 339 349 2015 26520840

상세보기
30 Lin NU Lee EQ Aoyama H Barani IJ Barboriak DP Baumert BG Response assessment criteria for brain metastases: proposal from the RANO group Lancet Oncol 16 e270 e278 2015 26065612

상세보기
31 Morris PG Reiner AS Szenberg OR Clarke JL Panageas KS Perez HR Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy J Thorac Oncol 7 382 385 2012 22089116

상세보기
32 Nakagawa H Kubo S Murasawa A Nakajima S Nakajima Y Izumoto S Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors J Neurooncol 12 111 120 1992 1560255
33 Shim Y Gwak HS Kim S Joo J Shin SH Yoo H Retrospective analysis of cerebrospinal fluid profiles in 228 patients with leptomeningeal carcinomatosis : differences according to the sampling site, symptoms, and systemic factors J Korean Neurosurg Soc 59 570 576 2016 27847569

원문보기 상세보기
34 Singh SK Agris JM Leeds NE Ginsberg LE Intracranial leptomeningeal metastases: comparison of depiction at FLAIR and contrast-enhanced MR imaging Radiology 217 50 53 2000 11012422

상세보기
35 Singh SK Leeds NE Ginsberg LE MR imaging of leptomeningeal metastases: comparison of three sequences AJNR Am J Neuroradiol 23 817 821 2002 12006284
36 Taillibert S Laigle-Donadey F Chodkiewicz C Sanson M Hoang-Xuan K Delattre JY Leptomeningeal metastases from solid malignancy: a review J Neurooncol 75 85 99 2005 16215819

상세보기
37 Teplyuk NM Mollenhauer B Gabriely G Giese A Kim E Smolsky M MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity Neuro Oncol 14 689 700 2012 22492962
38 Therasse P Arbuck SG Eisenhauer EA Wanders J Kaplan RS Rubinstein L New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 2000 10655437
39 Tu Q Wu X Le Rhun E Blonski M Wittwer B Taillandier L CellSearch technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis Lung Cancer 90 352 357 2015 26386833
40 Twijnstra A van Zanten AP Hart AA Ongerboer de Visser BW Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours J Neurol Neurosurg Psychiatry 50 313 320 1987 3559613

상세보기
41 Waki F Ando M Takashima A Yonemori K Nokihara H Miyake M Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors J Neurooncol 93 205 212 2009 19043775

상세보기
42 Wasserstrom WR Glass JP Posner JB Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients Cancer 49 759 772 1982 6895713

상세보기
43 Wen PY Macdonald DR Reardon DA Cloughesy TF Sorensen AG Galanis E Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 1963 1972 2010 20231676

상세보기
44 Yap HY Yap BS Rasmussen S Levens ME Hortobagyi GN Blumenschein GR Treatment for meningeal carcinomatosis in breast cancer Cancer 50 219 222 1982 6177395

상세보기
45 Yousem DM Patrone PM Grossman RI Leptomeningeal metastases: MR evaluation J Comput Assist Tomogr 14 255 261 1990 2312855

상세보기

LOADING...

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증